交易 Beam Therapeutics Inc. - BEAM CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.14 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Beam Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 33.90 | 0.45 | 1.35% | 33.45 | 34.13 | 32.73 |
Mar 26, 2024 | 33.14 | -0.81 | -2.39% | 33.95 | 34.44 | 33.13 |
Mar 25, 2024 | 33.62 | 0.10 | 0.30% | 33.52 | 34.17 | 33.29 |
Mar 22, 2024 | 33.55 | -1.12 | -3.23% | 34.67 | 34.69 | 33.33 |
Mar 21, 2024 | 34.88 | -0.61 | -1.72% | 35.49 | 36.56 | 34.49 |
Mar 20, 2024 | 34.82 | 0.37 | 1.07% | 34.45 | 35.64 | 33.69 |
Mar 19, 2024 | 34.75 | 1.10 | 3.27% | 33.65 | 35.09 | 33.33 |
Mar 18, 2024 | 34.00 | -1.05 | -3.00% | 35.05 | 35.38 | 33.97 |
Mar 15, 2024 | 35.34 | 1.36 | 4.00% | 33.98 | 35.37 | 33.45 |
Mar 14, 2024 | 34.51 | -2.16 | -5.89% | 36.67 | 36.94 | 33.76 |
Mar 13, 2024 | 37.30 | 2.23 | 6.36% | 35.07 | 37.42 | 34.95 |
Mar 12, 2024 | 35.75 | -1.20 | -3.25% | 36.95 | 36.95 | 35.25 |
Mar 11, 2024 | 36.51 | -0.44 | -1.19% | 36.95 | 38.11 | 36.27 |
Mar 8, 2024 | 37.46 | -0.11 | -0.29% | 37.57 | 38.81 | 36.81 |
Mar 7, 2024 | 36.89 | -1.41 | -3.68% | 38.30 | 38.94 | 36.73 |
Mar 6, 2024 | 38.21 | -1.44 | -3.63% | 39.65 | 39.95 | 37.46 |
Mar 5, 2024 | 38.42 | 0.97 | 2.59% | 37.45 | 38.82 | 37.05 |
Mar 4, 2024 | 38.15 | -2.10 | -5.22% | 40.25 | 40.41 | 37.97 |
Mar 1, 2024 | 39.75 | 0.00 | 0.00% | 39.75 | 41.15 | 38.99 |
Feb 29, 2024 | 39.39 | -5.35 | -11.96% | 44.74 | 44.79 | 38.73 |
Beam Therapeutics Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 8, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Beam Therapeutics Inc Earnings Release Q1 2024 Beam Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, June 5, 2024 | ||
時間 (UTC) 15:30 | 國家 US
| 事件 Beam Therapeutics Inc Annual Shareholders Meeting Beam Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 60.92 | 51.844 | 0.024 | 0.018 | 0 |
總營業費用 | 399.399 | 444.309 | 132.784 | 75.172 | 45.741 |
銷售/一般/行政費用,總計 | 87.805 | 57.222 | 29.605 | 20.553 | 11.868 |
研究與開發 | 311.594 | 387.087 | 103.179 | 54.619 | 33.873 |
營業收入 | -338.479 | -392.465 | -132.76 | -75.154 | -45.741 |
利息收入(費用),非經營淨值 | 59.397 | -1.009 | -61.832 | -3.101 | -11.457 |
其他,淨值 | 18.904 | 22.836 | -0.071 | -59.54 | |
稅前淨收入 | -260.178 | -370.638 | -194.592 | -78.326 | -116.738 |
稅後淨收入 | -263.588 | -370.638 | -194.592 | -78.326 | -116.738 |
少數股東權益 | 0 | 1.481 | |||
未計算非常項目前的淨收益 | -289.088 | -370.638 | -194.592 | -78.326 | -115.257 |
淨收入 | -289.088 | -370.638 | -194.592 | -78.326 | -115.257 |
Total Adjustments to Net Income | 0 | 0 | -1.277 | -12.714 | -2.068 |
普通股股東可獲收益 (不含非經常性項目) | -289.088 | -370.638 | -195.869 | -91.04 | -117.325 |
普通股股東可獲收益 (含非經常性項目) | -289.088 | -370.638 | -195.869 | -91.04 | -117.325 |
攤薄淨收入 | -289.088 | -370.638 | -195.869 | -91.04 | -117.325 |
攤薄後加權平均股 | 70.0153 | 64.2277 | 46.7332 | 45.3248 | 45.3248 |
扣除特別項目的每股攤薄盈利 | -4.12893 | -5.77069 | -4.19122 | -2.00861 | -2.58854 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -4.12893 | -5.77069 | -4.19122 | -2.00861 | -2.58854 |
收入 | 60.92 | 51.844 | 0.024 | 0.018 | |
Equity In Affiliates | -25.5 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 20.116 | 24.208 | 20.037 | 15.799 | 16.652 |
收入 | 20.116 | 24.208 | 20.037 | 15.799 | 16.652 |
總營業費用 | 122.264 | 123.136 | 109.022 | 107.102 | 98.618 |
銷售/一般/行政費用,總計 | 24.656 | 23.49 | 22.681 | 21.815 | 24.062 |
研究與開發 | 97.608 | 99.646 | 86.341 | 85.287 | 74.556 |
營業收入 | -102.148 | -98.928 | -88.985 | -91.303 | -81.966 |
利息收入(費用),非經營淨值 | 17.201 | 2.764 | 32.189 | 10.513 | 10.136 |
其他,淨值 | 2.171 | -0.296 | 19.447 | -0.875 | -0.12 |
稅前淨收入 | -82.776 | -96.46 | -37.349 | -81.665 | -71.95 |
稅後淨收入 | -82.776 | -96.46 | -38.349 | -84.075 | -71.95 |
未計算非常項目前的淨收益 | -82.776 | -96.46 | -38.349 | -109.575 | -71.95 |
淨收入 | -82.776 | -96.46 | -38.349 | -109.575 | -71.95 |
普通股股東可獲收益 (不含非經常性項目) | -82.776 | -96.46 | -38.349 | -109.575 | -71.95 |
普通股股東可獲收益 (含非經常性項目) | -82.776 | -96.46 | -38.349 | -109.575 | -71.95 |
攤薄淨收入 | -82.776 | -96.46 | -38.349 | -109.575 | -71.95 |
攤薄後加權平均股 | 76.3352 | 72.2738 | 70.7859 | 70.3432 | 70.2102 |
扣除特別項目的每股攤薄盈利 | -1.08438 | -1.33465 | -0.54176 | -1.55772 | -1.02478 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.08438 | -1.33465 | -0.54176 | -1.55772 | -1.02478 |
Total Adjustments to Net Income | 0 | ||||
Equity In Affiliates | 0 | -25.5 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 1092.9 | 1273.01 | 308.321 | 94.544 | 148.275 |
現金和短期投資 | 1078.13 | 965.647 | 299.671 | 91.848 | 146.443 |
現金等價物 | 232.767 | 559.994 | 162.171 | 37.221 | 146.443 |
預付的費用 | 14.762 | 7.36 | 8.65 | 2.696 | 1.832 |
總資産 | 1341.71 | 1474.45 | 451.677 | 156.099 | 167.012 |
物業/廠房/設備,總計 - 淨額 | 234.133 | 186.976 | 125.372 | 43.247 | 16.944 |
物業/廠房/設備,總計 - 總額 | 264.303 | 203.057 | 134.271 | 47.411 | 17.605 |
累計折舊,總計 | -30.17 | -16.081 | -8.899 | -4.164 | -0.661 |
其他長期資産,總計 | 14.685 | 14.47 | 17.984 | 18.308 | 1.793 |
流動負債總額 | 223.595 | 213.435 | 102.337 | 29.138 | 25.587 |
應付賬款 | 9.029 | 7.474 | 6.314 | 7.846 | 7.351 |
預提費用 | 58.439 | 75.204 | 22.705 | 12.189 | 1.734 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 1.853 | 2.287 | 2.118 | 1.303 | 13.75 |
其他流動負債,總計 | 154.274 | 128.47 | 71.2 | 7.8 | 2.752 |
負債總額 | 608.24 | 647.715 | 206.116 | 55.154 | 32.984 |
長期債務總額 | 1.154 | 3.007 | 5.294 | 4.411 | 0 |
其他負債,總計 | 383.491 | 431.273 | 98.485 | 21.605 | 7.397 |
股權 | 733.474 | 826.738 | 245.561 | 100.945 | 134.028 |
Redeemable Preferred Stock | 0 | 0 | 0 | 302.049 | 251.434 |
普通股 | 0.712 | 0.684 | 0.573 | 0.073 | 0.25 |
額外實收資本 | 1792.55 | 1594.38 | 642.633 | 1.851 | 7.062 |
留存收益(累計赤字) | -1057.36 | -768.274 | -397.636 | -203.044 | -124.718 |
總負債和股東權益 | 1341.71 | 1474.45 | 451.677 | 156.099 | 167.012 |
已發行普通股總數 | 71.2773 | 68.3894 | 57.2542 | 45.3248 | 45.3248 |
短期投資 | 845.367 | 405.653 | 137.5 | 54.627 | |
資本租賃義務 | 1.154 | 3.007 | 5.294 | 4.411 | |
其他權益,總計 | -2.43 | -0.05 | -0.009 | 0.016 | |
應收賬款總額,淨額 | 0 | 300 | |||
應收賬款 - 貿易,淨額 | 0 | 300 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 1039.54 | 1094.81 | 1083.03 | 1092.9 | 1108.91 |
現金和短期投資 | 1015.46 | 1073.02 | 1059.47 | 1078.13 | 1094.55 |
現金等價物 | 169.049 | 225.544 | 249.771 | 232.767 | 156.511 |
短期投資 | 846.408 | 847.472 | 809.7 | 845.367 | 938.043 |
預付的費用 | 24.084 | 21.789 | 23.56 | 14.762 | 14.358 |
總資産 | 1290.53 | 1353.89 | 1332.35 | 1341.71 | 1350.25 |
物業/廠房/設備,總計 - 淨額 | 239.661 | 242.278 | 237.981 | 234.133 | 226.714 |
物業/廠房/設備,總計 - 總額 | 284.481 | 281.911 | 272.798 | 264.303 | 252.94 |
累計折舊,總計 | -44.82 | -39.633 | -34.817 | -30.17 | -26.226 |
其他長期資産,總計 | 11.332 | 16.804 | 11.34 | 14.685 | 14.624 |
流動負債總額 | 220.365 | 209.536 | 219.925 | 223.595 | 238.859 |
應付賬款 | 3.177 | 6.886 | 14.063 | 9.029 | 7.024 |
預提費用 | 53.72 | 49.011 | 49.004 | 58.439 | 48.423 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 1.084 | 0.912 | 1.421 | 1.853 | 2.21 |
其他流動負債,總計 | 162.384 | 152.727 | 155.437 | 154.274 | 181.202 |
負債總額 | 511.593 | 542.244 | 570.846 | 608.24 | 635.773 |
長期債務總額 | 0.304 | 0.875 | 0.983 | 1.154 | 1.388 |
資本租賃義務 | 0.304 | 0.875 | 0.983 | 1.154 | 1.388 |
其他負債,總計 | 290.924 | 331.833 | 349.938 | 383.491 | 395.526 |
股權 | 778.941 | 811.643 | 761.506 | 733.474 | 714.477 |
普通股 | 0.794 | 0.78 | 0.744 | 0.712 | 0.705 |
額外實收資本 | 2112.86 | 2049.48 | 1915.35 | 1792.55 | 1737.46 |
留存收益(累計赤字) | -1332.69 | -1236.6 | -1153.82 | -1057.36 | -1019.01 |
其他權益,總計 | -2.024 | -2.015 | -0.765 | -2.43 | -4.674 |
總負債和股東權益 | 1290.53 | 1353.89 | 1332.35 | 1341.71 | 1350.25 |
已發行普通股總數 | 79.382 | 77.9535 | 74.4354 | 71.2773 | 70.4577 |
應收賬款總額,淨額 | 0 | 0 | |||
應收賬款 - 貿易,淨額 | 0 | 0 | |||
長期投資 | |||||
Redeemable Preferred Stock | 0 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -289.088 | -370.638 | -194.592 | -78.326 | -116.738 |
經營活動産生的現金 | 22.527 | -66.268 | -95.741 | -72.003 | -20.298 |
經營活動産生的現金 | 14.147 | 7.451 | 4.735 | 3.503 | 0.65 |
非現金物品 | 45.84 | 185.665 | 88.769 | 13.525 | 85.715 |
營運資金的變化 | 251.628 | 111.254 | 5.347 | -10.705 | 10.075 |
投資活動産生的現金 | -461.336 | -294.144 | -100.123 | -66.659 | -13.424 |
資本支出 | -48.951 | -46.811 | -16.357 | -12.518 | -13.124 |
其他投資現金流量項目,總計 | -412.385 | -247.333 | -83.766 | -54.141 | -0.3 |
融資活動産生的現金 | 111.59 | 756.141 | 322.322 | 41.279 | 179.727 |
股票的發行(報廢),淨額 | 114.065 | 767.075 | 322.683 | 38.086 | 179.727 |
現金淨變化 | -327.219 | 395.729 | 126.458 | -97.383 | 146.005 |
融資現金流項目 | -0.188 | -8.816 | -2.059 | -2.521 | |
債務的發行(退還),淨額 | -2.287 | -2.118 | 1.698 | 5.714 | |
已付現金利息 | 0.376 | 0.567 | 0.561 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -96.46 | -289.088 | -250.739 | -141.164 | -69.214 |
Cash From Operating Activities | -109.815 | 22.527 | 91.718 | 166.214 | 218.49 |
Cash From Operating Activities | 4.647 | 14.147 | 10.203 | 6.73 | 3.312 |
Non-Cash Items | 26.832 | 45.84 | 70.275 | 28.296 | 13.278 |
Cash Interest Paid | 0.062 | 0.376 | 0.3 | 0.214 | 0.113 |
Changes in Working Capital | -44.834 | 251.628 | 261.979 | 272.352 | 271.114 |
Cash From Investing Activities | 25.451 | -461.336 | -574.775 | -538.601 | -537.339 |
Capital Expenditures | -6.017 | -48.951 | -40.69 | -28.903 | -7.259 |
Other Investing Cash Flow Items, Total | 31.468 | -412.385 | -534.085 | -509.698 | -530.08 |
Cash From Financing Activities | 98.416 | 111.59 | 79.578 | 78.016 | 55.676 |
Financing Cash Flow Items | -0.062 | -0.188 | -0.134 | -0.109 | -0.006 |
Issuance (Retirement) of Stock, Net | 99.081 | 114.065 | 81.409 | 79.243 | 56.235 |
Issuance (Retirement) of Debt, Net | -0.603 | -2.287 | -1.697 | -1.118 | -0.553 |
Net Change in Cash | 14.052 | -327.219 | -403.479 | -294.371 | -263.173 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
26 Landsdowne St
CAMBRIDGE
MASSACHUSETTS 02139-4216
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易